News

 

Market analysis of Iconovo by Erik Penser Bank (only in Swedish)

Analys från Penser access: Iconovo - Amneal är tillbaka. Läs mera här

Abbreviated Annual Report 2019 available in English

Iconovo has made an abbreviated annual report for 2019 available in English for a non-Swedish speaking audience that wants to learn about Iconovo. Please…

New partnership adds support to development of Iconovo’s Symbicort generic

The Lund-based inhaler experts Iconovo are on the front lines of the fight against asthma, and they recently announced a new partnership dedicated to the…

Development of Iconovo AB’s generic Symbicort project transferred to the global partner Amneal

Iconovo AB today announced that the ICOres™ budesonide/formoterol project (generic Symbicort®) will be transferred to the global partner Amneal Ireland…

Positive patent news for Iconovo’s multidose inhaler

Positive patent news for Iconovo’s multidose inhaler The European Patent Organization, EPO, has announced the intention to grant a patent regarding…

Analysts see high value in Iconovo business

As Iconovo solidifies its product development and takes aim at a global market, a new analysis by Danske Bank indicates that the inhaler development company…

Market analysis of Iconovo by Danske Bank – The same but different

Iconovo develops drug inhalation products, offering exposure to the growing market for inhaled generics in the treatment of asthma and COPD. It has managed…

Iconovo boosts patent protection for ICOone

Iconovo, a Swedish inhalation device company, prides itself for being able to provide a wide range of generic inhalation devices and associated drug formulations. They…

Iconovo marginally impacted by Coronavirus pandemic

The spread of the new Coronavirus is affecting business world-wide. For some companies, however, the economic strain is minimal. This is the case for the…

World TB Day: Iconovo’s ICOone platform in the spotlight

Tuberculosis (TB) remains one of the top infectious killers, causing more deaths than malaria or AIDS. Today, on World Tuberculosis Day, BioStock takes…